Antitrust Antitrust

Plaintiffs in Lyme disease treatment antitrust case lack evidence of conspiracy, US judge told (correct*)

By Khushita Vasant
  • 23 Apr 2021 18:15
  • 24 Apr 2021 20:08
Antitrust claims against the Infectious Diseases Society of America alleging monopoly power and conspiracy to deny treatments for Lyme disease should be thrown out for lack of evidence, IDSA told a federal judge today. Counsel for plaintiffs, meanwhile, were questioned by the judge over the discovery process.

IDSA counsel Alvin Dunn told the

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News